Robert A. Lenz
Director · NovaBridge Biosciences
IndividualSelling only2 10b5-1 trades
- 2024
- Aug 25, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Robert A. Lenz files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mark Arnold Hagler - $577K in NBP purchases and sales in the last 12 months
- Sean Wuxiong Cao - $122K in NBP purchases and sales in the last 12 months
- Cong Claire Xu - $20K in NBP purchases and sales in the last 12 months
- Phillip Andrew Dennis - $11K in NBP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Robert A. Lenz?
Robert A. Lenz is a corporate insider, tracked as Director of NovaBridge Biosciences (NBP). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Robert A. Lenz submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Robert A. Lenz been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($208K) across all tracked filings.
